Trump Administration Outlines Plan for 200% Tariffs on Generic Pharmaceuticals

Key Regulatory Content

President Trump announced plans to impose tariffs of up to 200% on generic pharmaceuticals. To mitigate immediate market shocks, the administration will maintain duty-free status for qualifying goods for the next two years before implementing a phased increase in tariff rates.

Compliance Checklist

Pharmaceutical and logistics companies must evaluate supply chain diversification within the two-year grace period. It is critical to verify the eligibility of products for current duty-free status and conduct simulations on how tariff hikes will impact inventory costs and overall logistics expenditure.

Risk Mitigation Measures

To navigate these trade barriers, firms should consider localizing production or relocating supply chain hubs. Leveraging the transition period to enhance supply chain visibility and developing cost-optimization strategies will be essential to buffer the impact of rising logistics costs on final consumer pricing.

---

Original source: Supply Chain Dive